![]() |
市场调查报告书
商品编码
1348454
静脉注射套组的全球市场:规模,占有率,趋势分析(2024年~2030年):MedCoreIntravenous Set Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Pump Sets, Secondary Sets, and 2 more |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2023年,全球静脉注射器市场规模预计将呈现稳定成长,总估值达60亿美元,较上年的57亿美元大幅成长5.1%。该市场在预测期内继续以 4.1% 的复合年增长率成长,预计最终将达到 79 亿美元。全球静脉注射器市场的现况很大程度取决于两大参与者的存在:碧迪公司(BD)和贝朗公司。
随着外科和创伤领域的不断发展,静脉注射器的需求显着增加。无论是在繁忙的医院手术室还是在繁忙的门诊环境中,输液治疗都作为准确管理和施用输液和药物的生命线发挥着至关重要的作用。此外,在紧急医疗情况、危重治疗情况和创伤病例中,快速可靠地进入静脉对于復苏和稳定目的至关重要。正是在这些紧张的时刻,在持续血管通路的基本需求的推动下,对静脉输液器的需求急剧上升。
2023年,Becton Dickinson (BD) 成为全球静脉注射器市场的领导者。BD多年来在输液治疗及相关治疗市场各个方面的强势地位,为其推动这一领先地位发挥了至关重要的作用。BD的独特优势在于其能够将静脉输液器与多种配套产品捆绑在一起,这项策略为公司带来了显着的效益。这项策略使 BD 能够以竞争对手无法匹敌的每套价格提供大量 IV 套装。
本报告提供全球静脉注射套组市场相关调查,提供市场概要,以及各市场区隔,各地区趋势,竞争情形等资讯。
In 2023, the worldwide market for intravenous (IV) sets exhibited robust growth, with a total valuation of $6.0 billion, marking a substantial 5.1% increase from the previous year when it stood at $5.7 billion. Projections indicate continued growth momentum throughout the forecast period, with a compound annual growth rate (CAGR) of 4.1%, ultimately reaching an estimated value of $7.9 billion. Notably, the current landscape of the global intravenous set market is predominantly influenced by the presence of two major players, namely Becton Dickinson (BD) and B. Braun.
Our extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 intravenous set companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global market for intravenous sets encompasses a range of categories, including pump sets, secondary sets, gravity sets, and extension sets.
Within the ever-evolving realm of surgical procedures and trauma cases, there is a notable upswing in the demand for intravenous (IV) sets. Whether within the bustling confines of hospital operating rooms or in more mobile ambulatory settings, IV therapy assumes a pivotal role as a lifeline for the controlled administration of fluids and medications with precision. Moreover, in instances of emergent medical scenarios, critical care situations, and traumatic injuries, the immediate and dependable access to veins becomes paramount for the purpose of resuscitation and stabilization. It is within these intense and time-sensitive moments that the requirement for IV sets experiences a significant surge, driven by the indispensable need for consistent vascular access.
In the year 2023, Becton Dickinson (BD) emerged as the foremost leader in the global IV set market. BD's entrenched position in various other facets of infusion therapy and related treatment markets over the years played a pivotal role in elevating it to this top-tier status. BD's distinctive advantage lies in its ability to bundle IV sets with a range of complementary products, a strategy that bestows significant benefits upon the company. This approach occasionally empowers BD to offer IV sets in substantial quantities and at a per-set cost that smaller competitors find challenging to match.
Claiming the second position in the global IV set market for 2023 was B. Braun. The company exhibited a robust presence in the pump set market, driven by its dominant role in the realm of large-volume infusion pumps. B. Braun held a significant market share in IV sets, particularly in key Western European markets such as Germany and Italy. Beyond Western Europe, the company maintained noteworthy, albeit somewhat smaller, shares in other regions.
The remaining segment of the IV set market remained fragmented, featuring a diverse array of competitors. The relatively modest manufacturing costs associated with IV sets make this sector an attractive space for smaller players to enter. Furthermore, the majority of companies engaged in the production and distribution of infusion pumps also complement their capital products with infusion sets, thereby contributing to the diversity of offerings within the market.